Carregant...
Rikkunshi-to attenuates adverse gastrointestinal symptoms induced by fluvoxamine
BACKGROUND: Upper gastrointestinal (GI) symptoms such as nausea and vomiting are common adverse events associated with selective serotonin reuptake inhibitors (SSRIs), and may result in discontinuation of drug therapy in patients with depressive disorder. Rikkunshi-to (formulation TJ-43), a traditio...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2007
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2204024/ https://ncbi.nlm.nih.gov/pubmed/18001480 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1751-0759-1-21 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|